Author Archives: Darren Marchal

Analysis In Real Time Is Only For Shock Value

Do you consider how inaccurate the monthly economic releases are? Every day, the markets react to the deviation from expectations for releases on employment, manufacturing, spending et al. No consideration is made to the backward revisions which effect HOW one should view the current data. Analysis of monthly movements are hardly ever correct as backward revisions,…

High Yield Breakdown

Could the high yield bond market be sending a precursor message to the Fed, signaling them not raise rates until 2016? While that’s a notable possibility, the market just doesn’t seem hungry enough to gobble up excess inventory from record outstanding high yield debt levels. Especially with intermediate to long-term fundamental challenges such as the…

Bank Stock Roundup: Q2 Earnings In Final Stretch; Comerica, SunTr

In the last five trading days, earnings releases were in full swing for banking stocks. Effective cost-control initiatives and absence of high legal expenses helped banks that have reported so far to outpace the respective Zacks Consensus Estimate. Banks were easily able to surpass estimates owing to downward revisions just before the releases. The concerns…

E

Shares of Sunesis (SNSS) are down 72% today after the company reported a regulatory update from both the FDA and EMA regulatory bodies. Sunesis is working on obtaining approval for Vosaroxin in both the U.S. and Europe, to treat patients with Acute Myeloid Leukemia — AML. AML is a blood cancer that inhibits proper cell…